Keystone Symposium

June 18th, 2019 – Keystone, CO, USA

Dieter Willbold will present PRI-002 at the Keystone Symposium “Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2) in Keystone, CO, USA.

News & Events:

Funding from The Michael J. Fox Foundation

24. Februar 2021

Priavoid closes financing round

12. Februar 2021

Sprunginnovationsprojekt geht neue Wege in der Alzheimer-Therapie

11. Februar 2021

Alzheimer´s Research: Important Milestone for PRI-002

4. Februar 2021

Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory board

9. Dezember 2020

New CEO of Priavoid

2. September 2020

Priavoid Headquarters at LSC Düsseldorf

6. März 2020

Seed Investment

6. Mai 2019

Prof. Willbold´s interview with PharmaVentures

23. Januar 2018

Clinical trial with PRI-002

31. Mai 2017